{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:35:34Z","timestamp":1788910534220,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mildly elevated bilirubin, a by-product of hemoglobin breakdown, might mitigate cardiometabolic risk factors including adiposity, dyslipidemia, and high blood pressure (BP). We investigated the cross-sectional relationship between (total) bilirubin and baseline cardiometabolic risk factors in 467,519 UK Biobank study participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used multivariable-adjusted linear regression to estimate associations between bilirubin levels and risk factors of cardiometabolic diseases including body mass index (BMI), waist and hip circumferences (WC, HC), waist-to-hip ratio (WHR), fat mass (FM), and trunk FM, and the blood lipids: apolipoprotein A-I (apoA-I), apolipoprotein B (apoB), apoB\/apoA-I, lipoprotein (a), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), LDL\/HDL, TC\/HDL, triglycerides (TG). Log-transformed bilirubin was modelled with restricted cubic splines and predicted mean values with 99% confidence intervals (CI) for each risk marker were estimated, separately. Second, we applied principal component analysis (PCA) for dimension reduction to in turn six anthropometric traits (height, weight, BMI, WC, HC, and WHR) and all above lipids. Last, we estimated associations (99%CI) between bilirubin and three components of the metabolic syndrome, i.e. WC, TG, and BP using logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After multivariable adjustments, higher levels of bilirubin were inversely associated with indicators of general adiposity (BMI and FM) and of body fat distribution (WC, HC, WHR, and trunk FM) in both men and women. For example, women with mildly elevated bilirubin (95\n                      <jats:sup>th<\/jats:sup>\n                      percentile equal to 15.0\u00a0\u00b5mol\/L), compared to women with low bilirubin (5\n                      <jats:sup>th<\/jats:sup>\n                      percentile equal to 4.5\u00a0\u00b5mol\/L), had on average a 2.0\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      (99% CI 1.9\u20132.1) lower BMI. Inverse associations were also observed with dyslipidemia among men and women. For example, mildly elevated bilirubin among men (95\n                      <jats:sup>th<\/jats:sup>\n                      percentile equal to 19.4\u00a0\u00b5mol\/L) compared to low levels of bilirubin (5\n                      <jats:sup>th<\/jats:sup>\n                      percentile equal to 5.5\u00a0\u00b5mol\/L) were associated with approx. 0.55\u00a0mmol\/L (99% CI 0.53\u20130.56) lower TG levels, with similar inverse associations among women. Multiple-trait analyses using PCA confirmed single-trait analyses. Men and women with mildly elevated bilirubin levels\u2009\u2265\u200917.1\u00a0\u00b5mol\/L, compared to low-normal bilirubin\u2009&lt;\u200910\u00a0\u00b5mol\/L had 13% (99% CI 8%\u201318%) and 11% (99% CI 4%\u201317%) lower odds of exceeding systolic BP levels of\u2009\u2265\u2009130\u00a0mm Hg, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher levels of bilirubin were inversely associated with cardiometabolic risk factors including adiposity, dyslipidemia, and hypertension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-022-01484-x","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T09:02:53Z","timestamp":1650272573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank"],"prefix":"10.1186","volume":"21","author":[{"given":"Nazlisadat","family":"Seyed Khoei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja M.","family":"Sedlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8648-4998","authenticated-orcid":false,"given":"Heinz","family":"Freisling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"1484_CR1","doi-asserted-by":"crossref","unstructured":"Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (London, England). 2016;388(10053):1659\u2013724.","DOI":"10.1016\/S0140-6736(16)31679-8"},{"issue":"3","key":"1484_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1365-2796.2006.01617.x","volume":"259","author":"M Ridderstr\u00e5le","year":"2006","unstructured":"Ridderstr\u00e5le M, Gudbj\u00f6rnsdottir S, Eliasson B, Nilsson PM, Cederholm J. Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med. 2006;259(3):314\u201322.","journal-title":"J Intern Med"},{"issue":"2","key":"1484_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1042\/CS20080050","volume":"116","author":"MJ Hill","year":"2009","unstructured":"Hill MJ, Metcalfe D, McTernan PG. Obesity and diabetes: lipids, \u201cnowhere to run to.\u201d Clinical science (London, England: 1979). 2009;116(2):113\u201323.","journal-title":"Clinical science (London, England: 1979)."},{"issue":"4","key":"1484_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/HYPERTENSIONAHA.118.11130","volume":"72","author":"TD Hinds Jr","year":"2018","unstructured":"Hinds TD Jr, Stec DE. Bilirubin, a cardiometabolic signaling molecule. Hypertension (Dallas, Tex: 1979). 2018;72(4):788\u201395.","journal-title":"Hypertension (Dallas, Tex: 1979)."},{"issue":"2","key":"1484_CR5","doi-asserted-by":"publisher","first-page":"F123","DOI":"10.1152\/ajprenal.00039.2014","volume":"307","author":"AC Boon","year":"2014","unstructured":"Boon AC, Bulmer AC, Coombes JS, Fassett RG. Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations. Am J Physiol Renal Physiol. 2014;307(2):F123\u201336.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"1484_CR6","doi-asserted-by":"publisher","first-page":"E244","DOI":"10.1152\/ajpendo.00396.2016","volume":"312","author":"TD Hinds Jr","year":"2017","unstructured":"Hinds TD Jr, Hosick PA, Chen S, Tukey RH, Hankins MW, Nestor-Kalinoski A, et al. Mice with hyperbilirubinemia due to Gilbert\u2019s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPAR\u03b1. Am J Physiol Endocrinol Metab. 2017;312(4):E244\u201352.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"1484_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/CS20120661","volume":"125","author":"M Wallner","year":"2013","unstructured":"Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vitek L, et al. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert\u2019s syndrome. Clinical science (London, England: 1979). 2013;125(5):257\u201364.","journal-title":"Clinical science (London, England: 1979)."},{"key":"1484_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2017.12.021","volume":"269","author":"N Seyed Khoei","year":"2018","unstructured":"Seyed Khoei N, Grindel A, Wallner M, Molzer C, Doberer D, Marculescu R, et al. Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: implications for improved metabolic health. Atherosclerosis. 2018;269:306\u201311.","journal-title":"Atherosclerosis"},{"issue":"10","key":"1484_CR9","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.freeradbiomed.2012.03.002","volume":"52","author":"AC Boon","year":"2012","unstructured":"Boon AC, Hawkins CL, Bisht K, Coombes JS, Bakrania B, Wagner KH, et al. Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome. Free Radical Biol Med. 2012;52(10):2120\u20137.","journal-title":"Free Radical Biol Med"},{"key":"1484_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fphar.2012.00055","volume":"3","author":"L Vitek","year":"2012","unstructured":"Vitek L. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front Pharmacol. 2012;3:55.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1484_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s13105-012-0154-2","volume":"68","author":"I Bondia-Pons","year":"2012","unstructured":"Bondia-Pons I, Ryan L, Martinez JA. Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem. 2012;68(4):701\u201311.","journal-title":"J Physiol Biochem"},{"issue":"1","key":"1484_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1365-2362.2011.02558.x","volume":"42","author":"M D'Archivio","year":"2012","unstructured":"D\u2019Archivio M, Annuzzi G, Var\u00ec R, Filesi C, Giacco R, Scazzocchio B, et al. Predominant role of obesity\/insulin resistance in oxidative stress development. Eur J Clin Invest. 2012;42(1):70\u20138.","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"1484_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.metabol.2013.01.011","volume":"62","author":"Z Jenko-Pra\u017enikar","year":"2013","unstructured":"Jenko-Pra\u017enikar Z, Petelin A, Jurdana M, \u017diberna L. Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: an early indicator of metabolic syndrome? Metab Clin Exp. 2013;62(7):976\u201385.","journal-title":"Metab Clin Exp."},{"issue":"6","key":"1484_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.numecd.2013.12.009","volume":"24","author":"ME J\u00f8rgensen","year":"2014","unstructured":"J\u00f8rgensen ME, Torp-Pedersen C, Finer N, Caterson I, James WP, Legler UF, et al. Association between serum bilirubin and cardiovascular disease in an overweight high risk population from the SCOUT trial. Nutr Metab Cardiovasc Dis. 2014;24(6):656\u201362.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"1484_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.numecd.2011.03.001","volume":"23","author":"SH Choi","year":"2013","unstructured":"Choi SH, Yun KE, Choi HJ. Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults. Nutr Metab Cardiovasc Dis. 2013;23(1):31\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"1484_CR16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.metabol.2007.12.003","volume":"57","author":"AR Bhuiyan","year":"2008","unstructured":"Bhuiyan AR, Srinivasan SR, Chen W, Sultana A, Berenson GS. Association of serum bilirubin with pulsatile arterial function in asymptomatic young adults: the Bogalusa Heart Study. Metab Clin Exp. 2008;57(5):612\u20136.","journal-title":"Metab Clin Exp."},{"issue":"3","key":"1484_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1753-0407.2011.00138.x","volume":"3","author":"Y Wu","year":"2011","unstructured":"Wu Y, Li M, Xu M, Bi Y, Li X, Chen Y, et al. Low serum total bilirubin concentrations are associated with increased prevalence of metabolic syndrome in Chinese. J Diabetes. 2011;3(3):217\u201324.","journal-title":"J Diabetes"},{"issue":"6","key":"1484_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1089\/jwh.2010.2453","volume":"20","author":"KM Kwon","year":"2011","unstructured":"Kwon KM, Kam JH, Kim MY, Kim MY, Chung CH, Kim JK, et al. Inverse association between total bilirubin and metabolic syndrome in rural korean women. J Women\u2019s Health (2002). 2011;20(6):963\u20139.","journal-title":"J Women's Health (2002)."},{"key":"1484_CR19","doi-asserted-by":"publisher","first-page":"30051","DOI":"10.1038\/srep30051","volume":"6","author":"C Molzer","year":"2016","unstructured":"Molzer C, Wallner M, Kern C, Tosevska A, Schwarz U, Zadnikar R, et al. Features of an altered AMPK metabolic pathway in Gilbert\u2019s Syndrome, and its role in metabolic health. Sci Rep. 2016;6:30051.","journal-title":"Sci Rep"},{"issue":"1","key":"1484_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20140566","volume":"129","author":"KH Wagner","year":"2015","unstructured":"Wagner KH, Wallner M, Molzer C, Gazzin S, Bulmer AC, Tiribelli C, et al. Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases. Clin Sci (London, England: 1979). 2015;129(1):1\u201325.","journal-title":"Clin Sci (London, England: 1979)."},{"issue":"14","key":"1484_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1161\/CIRCULATIONAHA.119.044562","volume":"141","author":"NJ Stone","year":"2020","unstructured":"Stone NJ, Blumenthal RS, Lloyd-Jones D, Grundy SM. Comparing primary prevention recommendations: a focused look at United States and European guidelines on dyslipidemia. Circulation. 2020;141(14):1117\u201320.","journal-title":"Circulation"},{"issue":"10","key":"1484_CR22","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1001\/archinte.167.10.1068","volume":"167","author":"PWF Wilson","year":"2007","unstructured":"Wilson PWF, Meigs JB, Sullivan L, Fox CS, Nathan DM, D\u2019Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007;167(10):1068\u201374.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1484_CR23","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"3","key":"1484_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00103-015-2297-0","volume":"59","author":"A Trehearne","year":"2016","unstructured":"Trehearne A. Genetics, lifestyle and environment. UK Biobank is an open access resource following the lives of 500,000 participants to improve the health of future generations. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016;59(3):361\u20137.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz."},{"key":"1484_CR25","unstructured":"UK Biobank: Protocol for a large-scale prospective epidemiological resource; 2007. http:\/\/www.ukbiobank.ac.uk\/wp-content\/uploads\/2011\/11\/UK-Biobank-Protocol.pdf."},{"issue":"10","key":"1484_CR26","doi-asserted-by":"publisher","first-page":"e0240413","DOI":"10.1371\/journal.pone.0240413","volume":"15","author":"H Sanikini","year":"2020","unstructured":"Sanikini H, Muller DC, Chadeau-Hyam M, Murphy N, Gunter MJ, Cross AJ. Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort. PloS One. 2020;15(10):e0240413.","journal-title":"PloS One."},{"key":"1484_CR27","doi-asserted-by":"publisher","unstructured":"Powell R, De Lucia Rolfe E, Day FR, Perry JRB, J. GS, Forouhi NG, et al. Development and validation of total and regional body composition prediction equations from anthropometry and single frequency segmental bioelectrical impedance with DEXA. medRxiv preprint. 2020; https:\/\/doi.org\/10.1101\/2020121620248330.","DOI":"10.1101\/2020121620248330"},{"issue":"2","key":"1484_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/10408363.2018.1428526","volume":"55","author":"KH Wagner","year":"2018","unstructured":"Wagner KH, Shiels RG, Lang CA, Seyed Khoei N, Bulmer AC. Diagnostic criteria and contributors to Gilbert\u2019s syndrome. Crit Rev Clin Lab Sci. 2018;55(2):129\u201339.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1484_CR29","doi-asserted-by":"publisher","first-page":"13357","DOI":"10.1038\/ncomms13357","volume":"7","author":"JS Ried","year":"2016","unstructured":"Ried JS, Jeff MJ, Chu AY, Bragg-Gresham JL, van Dongen J, Huffman JE, et al. A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape. Nat Commun. 2016;7:13357.","journal-title":"Nat Commun"},{"key":"1484_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2261-12-102","volume":"12","author":"DG Panazzolo","year":"2012","unstructured":"Panazzolo DG, Sicuro FL, Clapauch R, Maranh\u00e3o PA, Bouskela E, Kraemer-Aguiar LG. Obesity, metabolic syndrome, impaired fasting glucose, and microvascular dysfunction: a principal component analysis approach. BMC Cardiovasc Disord. 2012;12:102.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"1484_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/gerona\/glp005","volume":"64","author":"FC Hsu","year":"2009","unstructured":"Hsu FC, Kritchevsky SB, Liu Y, Kanaya A, Newman AB, Perry SE, et al. Association between inflammatory components and physical function in the health, aging, and body composition study: a principal component analysis approach. J Gerontol A Biol Sci Med Sci. 2009;64(5):581\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"1484_CR32","doi-asserted-by":"publisher","first-page":"e005520","DOI":"10.1161\/JAHA.117.005520","volume":"6","author":"D Wang","year":"2017","unstructured":"Wang D, Tosevska A, Hei\u00df EH, Ladurner A, M\u00f6lzer C, Wallner M, et al. Bilirubin decreases macrophage cholesterol efflux and atp-binding cassette transporter A1 protein expression. J Am Heart Assoc. 2017;6(5):e005520. https:\/\/doi.org\/10.1161\/JAHA.117.005520.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1484_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/clinchem\/40.1.18","volume":"40","author":"HA Schwertner","year":"1994","unstructured":"Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994;40(1):18\u201323.","journal-title":"Clin Chem"},{"key":"1484_CR34","doi-asserted-by":"crossref","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001;285(19):2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"issue":"2","key":"1484_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2007.11.022","volume":"199","author":"AC Bulmer","year":"2008","unstructured":"Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS. Improved resistance to serum oxidation in Gilbert\u2019s syndrome: a mechanism for cardiovascular protection. Atherosclerosis. 2008;199(2):390\u20136.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1484_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.plipres.2012.11.001","volume":"52","author":"AC Bulmer","year":"2013","unstructured":"Bulmer AC, Verkade HJ, Wagner KH. Bilirubin and beyond: a review of lipid status in Gilbert\u2019s syndrome and its relevance to cardiovascular disease protection. Prog Lipid Res. 2013;52(2):193\u2013205.","journal-title":"Prog Lipid Res"},{"key":"1484_CR37","doi-asserted-by":"publisher","first-page":"9886","DOI":"10.1038\/srep09886","volume":"5","author":"J Liu","year":"2015","unstructured":"Liu J, Dong H, Zhang Y, Cao M, Song L, Pan Q, et al. Bilirubin increases insulin sensitivity by regulating cholesterol metabolism. adipokines and PPAR\u03b3 levels. Sci Rep. 2015;5:9886.","journal-title":"Sci Rep"},{"issue":"4","key":"1484_CR38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/tpj.2012.9","volume":"13","author":"AC Frazier-Wood","year":"2013","unstructured":"Frazier-Wood AC, Ordovas JM, Straka RJ, Hixson JE, Borecki IB, Tiwari HK, et al. The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study. Pharmacogenomics J. 2013;13(4):312\u20137.","journal-title":"Pharmacogenomics J"},{"issue":"19","key":"1484_CR39","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","volume":"98","author":"B Staels","year":"1998","unstructured":"Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98(19):2088\u201393.","journal-title":"Circulation"},{"issue":"6","key":"1484_CR40","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.metabol.2006.01.020","volume":"55","author":"AV Ferreira","year":"2006","unstructured":"Ferreira AV, Parreira GG, Green A, Botion LM. Effects of fenofibrate on lipid metabolism in adipose tissue of rats. Metab Clin Exp. 2006;55(6):731\u20135.","journal-title":"Metab Clin Exp."},{"issue":"6","key":"1484_CR41","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/0006-2952(95)02395-X","volume":"51","author":"TW Wu","year":"1996","unstructured":"Wu TW, Fung KP, Wu J, Yang CC, Weisel RD. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol. 1996;51(6):859\u201362.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1484_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa043175","volume":"353","author":"S Tsimikas","year":"2005","unstructured":"Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med. 2005;353(1):46\u201357.","journal-title":"N Engl J Med"},{"issue":"1","key":"1484_CR43","first-page":"8","volume":"17","author":"EU Nwose","year":"2012","unstructured":"Nwose EU, Richards RS, Bwititi P, Butkowski E. Serum bilirubin and lipoprotein-a: how are these associated with whole blood viscosity? Redox Rep Commun Free Radical Res. 2012;17(1):8\u201313.","journal-title":"Redox Rep Commun Free Radical Res"},{"key":"1484_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.exger.2015.09.014","volume":"72","author":"SK Kunutsor","year":"2015","unstructured":"Kunutsor SK. Serum total bilirubin levels and coronary heart disease\u2013causal association or epiphenomenon? Exp Gerontol. 2015;72:63\u20136.","journal-title":"Exp Gerontol"},{"key":"1484_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.atherosclerosis.2020.12.005","volume":"320","author":"L Hou","year":"2021","unstructured":"Hou L, Li H, Si S, Yu Y, Sun X, Liu X, et al. Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: observational findings and Mendelian randomization studies. Atherosclerosis. 2021;320:112\u201321.","journal-title":"Atherosclerosis"},{"issue":"8","key":"1484_CR46","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2009.04.003","volume":"58","author":"C Andersson","year":"2009","unstructured":"Andersson C, Weeke P, Fosbol EL, Brendorp B, Kober L, Coutinho W, et al. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. Metab Clin Exp. 2009;58(8):1109\u201315.","journal-title":"Metab Clin Exp."},{"issue":"29","key":"1484_CR47","doi-asserted-by":"publisher","first-page":"9804","DOI":"10.1074\/jbc.RA120.013700","volume":"295","author":"DM Gordon","year":"2020","unstructured":"Gordon DM, Neifer KL, Hamoud AA, Hawk CF, Nestor-Kalinoski AL, Miruzzi SA, et al. Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor \u03b1. J Biol Chem. 2020;295(29):9804\u201322.","journal-title":"J Biol Chem"},{"issue":"5","key":"1484_CR48","first-page":"201","volume":"2","author":"P Cheriyath","year":"2010","unstructured":"Cheriyath P, Gorrepati VS, Peters I, Nookala V, Murphy ME, Srouji N, et al. High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999\u20132006. J Clin Med Res. 2010;2(5):201\u20136.","journal-title":"J Clin Med Res"},{"key":"1484_CR49","doi-asserted-by":"publisher","first-page":"100114","DOI":"10.1016\/j.metop.2021.100114","volume":"11","author":"AC Uribe-Weichers","year":"2021","unstructured":"Uribe-Weichers AC, G\u00f3mez-P\u00e9rez FJ, Lam-Chung CE, Cuevas-Ramos D. Patients with Gilbert syndrome and type 2 diabetes have lower prevalence of microvascular complications. Metab Open. 2021;11:100114.","journal-title":"Metab Open."},{"issue":"3","key":"1484_CR50","first-page":"495","volume":"66","author":"M Guzek","year":"2012","unstructured":"Guzek M, Jakubowski Z, Bandosz P, Wyrzykowski B, Smoczy\u0144ski M, Jabloiska A, et al. Inverse association of serum bilirubin with metabolic syndrome and insulin resistance in Polish population. Przegl Epidemiol. 2012;66(3):495\u2013501.","journal-title":"Przegl Epidemiol"},{"issue":"1","key":"1484_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12902-020-00563-y","volume":"20","author":"H Hao","year":"2020","unstructured":"Hao H, Guo H, Ma RL, Yan YZ, Hu YH, Ma JL, et al. Association of total bilirubin and indirect bilirubin content with metabolic syndrome among Kazakhs in Xinjiang. BMC Endocr Disord. 2020;20(1):110.","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"1484_CR52","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1161\/ATVBAHA.117.310071","volume":"37","author":"AJ Amor","year":"2017","unstructured":"Amor AJ, Ortega E, Perea V, Cof\u00e1n M, Sala-Vila A, Nu\u00f1ez I, et al. Relationship between total serum bilirubin levels and carotid and femoral atherosclerosis in familial dyslipidemia. Arterioscler Thromb Vasc Biol. 2017;37(12):2356\u201363.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"1484_CR53","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/ijms17070999","volume":"17","author":"AS Lagan\u00e0","year":"2016","unstructured":"Lagan\u00e0 AS, Vitale SG, Nigro A, Sofo V, Salmeri FM, Rossetti P, et al. Pleiotropic actions of peroxisome proliferator-activated receptors (PPARs) in dysregulated metabolic homeostasis, inflammation and cancer: current evidence and future perspectives. Int J Mol Sci. 2016;17(7):999.","journal-title":"Int J Mol Sci"},{"key":"1484_CR54","doi-asserted-by":"publisher","first-page":"108973","DOI":"10.1016\/j.biopha.2019.108973","volume":"116","author":"Y Lin","year":"2019","unstructured":"Lin Y, Wang S, Yang Z, Gao L, Zhou Z, Yu P, et al. Bilirubin alleviates alum-induced peritonitis through inactivation of NLRP3 inflammasome. Biomed Pharmacother Biomed Pharmacotherapie. 2019;116:108973.","journal-title":"Biomed Pharmacother Biomed Pharmacotherapie."},{"issue":"9","key":"1484_CR55","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.2174\/13816128113199990559","volume":"20","author":"M Mishra","year":"2014","unstructured":"Mishra M, Ndisang JF. A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes. Curr Pharm Des. 2014;20(9):1370\u201391.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1484_CR56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ije\/dyx206","volume":"47","author":"MR Munaf\u00f2","year":"2017","unstructured":"Munaf\u00f2 MR, Tilling K, Taylor AE, Evans DM, Davey SG. Collider scope: when selection bias can substantially influence observed associations. Int J Epidemiol. 2017;47(1):226\u201335.","journal-title":"Int J Epidemiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01484-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T13:09:22Z","timestamp":1650373762000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01484-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1484"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01484-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The UKB obtained full ethical approval from the North West Multi-centre Research Ethics Committee, the National Information Governance Board for Health and Social Care in England and Wales, and the Community Health Index Advisory Group in Scotland. Additionally, in 2004, an independent Ethics and Governance Council was formed to oversee UKB\u2019s continuous adherence to the Ethics and Governance Framework that was developed for the study (\n                      \n                      ). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}